http://www.nytimes.com/aponline/national/AP-EXP-Transporting-Vaccines.html
December 23, 2001
|
|
|
|
CENTERVILLE, Ohio (AP) -- The same technology that keeps takeout pizza hot
is being used to keep vaccines cool, bringing increased demand for the
refrigeration units since the East Coast terrorist attacks.
``Everybody is suddenly extremely aware of chemical and biological
warfare,'' said Chris Meyer, a director for Energy Storage Technologies Inc.
``That's what we're responding to now.''
The company produces refrigerators that are tightly insulated and have pumps
that keep temperatures to within a few degrees -- essential to preserve anthrax
vaccine. It also makes a portable cooler with a wax-based liquid that keeps the
vaccines cool without freezing them. The same liquid is used to keep pizzas hot
through a reverse process.
The 110-pound refrigerators, which are usually sold along with the cooler as
one system, have been in production for about two years. The surge in demand
since the Sept. 11 attacks has forced the company to increase its production
work force from 10 to 18 employees and begin eight-hour overtime shifts on
Saturdays. Production is expected to increase from a few units a week to 40.
The company's one-story, brick factory connects to other businesses at a
modern industrial park in this city 10 miles south of Dayton. Inside,
refrigerators are lined up like giant marshmallows. The whine of saws cutting
insulation fills the air.
The Centers for Disease Control has ordered 286 units to store anthrax
vaccines at various places around the nation for civil defense, Meyer said.
Company President Lloyd Huff said conventional refrigerators do not have the
appropriate temperature control for vaccines and are vulnerable to power
outages.
``As soon as you get into some sort of threatening situation, there's a
strong likelihood you won't have power,'' he said.
Anthrax vaccines must be stored between 36 degrees and 46 degrees. If
electrical power fails, the refrigerator has a battery that can maintain the
temperature for up to four days.
Energy Storage Technologies was contacted four years ago by the Army, which
was looking into vaccinating troops for anthrax. Meyer said some of the Army
vaccines had gone bad because they were not properly refrigerated.
The Army ordered some prototype systems from Energy Storage and tested them.
It then bought 40 units and placed them around the world.
More orders followed.
The only American manufacturer of the anthrax vaccine, BioPort Inc. of
Lansing, Mich., has yet to win approval from the U.S. Food and Drug
Administration to ship the vaccine. The FDA was scheduled to inspect BioPort in
mid-December.
If the FDA approves distribution, the vaccine will likely go to troops and
others at risk for anthrax exposure, including law enforcement and postal
workers.
Huff said he expects business to increase if approval is granted.
The refrigerator sells for $3,500, the cooler $184. Energy Storage projects
sales of $10 million through 2002. That compares to sales of between $3 million
and $4 million in 2000 and 2001.
Huff said the refrigeration systems can also be used by underdeveloped
countries to preserve vaccines for smallpox, polio and other diseases.
One of the biggest challenges is to make sure the ``cold chain'' remains
unbroken. Vaccines must be kept within certain temperatures from the time they
are manufactured to when they are transported and used for inoculations.
``Health-care workers oftentimes will walk several hours carrying vaccines
with them that have to be kept cold,'' said Melinda Moree, senior business
development officer for the Seattle-based Program for Appropriate Technology in
Health.
PATH provides technical assistance to the World Health Organization and
works with clinics to improve the delivery of health services in developing
countries. Moree said there are growing efforts to use new technologies to
improve the cold chain.
^------
On the Net:
Program for Appropriate Technology in Health:
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.